🚀New Tool: stImage
Understanding how genes behave within the structure of tissues is key to unlocking new biological insights. Current tools for spatial transcriptomics often look at [...]
BIG THANK YOU to our Outgoing Cell & Tissue Mechanics Special Interest Group Chairs – Meenal Datta and Wenjun Wang!
The MC2 Center team is so grateful and - we know the community benefitted so much from for your past two years of service! [...]
📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma
Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]
🚀New Tool: SMoReGloS
Agent-based models (ABMs) are powerful tools for exploring how individual interactions lead to complex, emergent behaviors in biology, ecology, and society. Yet, assessing the [...]
🚀New Tool: EVOFLUx
Cancer evolves over time, but capturing these dynamics has long been a challenge. EVOFLUx is a new method that uses natural DNA methylation “barcodes” [...]
🧰 CCKP Toolkit Tool Feature: Tellurium
Tellurium is a Python environment for modeling and simulating biological systems. It provides a comprehensive toolkit for systems and synthetic biology, enabling researchers to [...]
Save the Date: 2026 All Consortia Meeting, October 20 – 22, 2026
We are excited to announce the 2026 MC2 Center All Consortia Meeting! In October 2026 we will bring together the CCBIR, CSBC, MetNet, PS-ON and [...]
📈New Dataset: Pancreatic cancer xenograft tumor RNA sequencing and pathologic differentiation of matched human tumors
From Brown et al. (https://pubmed.ncbi.nlm.nih.gov/38471099/), this dataset investigates the epithelial to mesenchymal transition (EMT) in pancreatic cancer. EMT is believed to correlate with metastatic [...]
🚀 Tool Spotlight: InterpolAI
InterpolAI is a deep learning-based tool that allows for advanced image analysis on biomedical images to help with 3D tissue mapping. Specifically, this tool [...]
New Dataset: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
This dataset investigates the effectiveness of p53 reactivation in treating glioblastoma. They achieve this by treating multiple patients with differing levels of MDM2 inhibitor [...]